Basic HTML Version
Û˘ÓÂÚÁ·Û›Â˜
ÚÔÛÊÔÚ¿ Ù¯ÓÔÏÔÁÈÒÓ
25
K · È Ó Ô Ù Ô Ì › · , Œ Ú Â ˘ Ó · Î · È ∆  ¯ Ó Ô Ï Ô Á › ·
05 ES MAOT
0CC2
05 ES MAOT
0C30
05 DE SDST
0CAJ
05 ES CACI
0CCC
05 IL ILMA
0CCE
05 DE HRIM
0CC7
05 ES MAOT
0C2U
05 DE SDST
0CAK
05 GB
WADA 0CCR
05 DE TSZP
0CCV
05 ES BCSP
0CDD
05 ES MADG
0C78
05 GB SCTI
0CBU
05 IE IEEI
0C5W
05 LV LVTC
0C96
ES
ES
DE
ES
IL
DE
ES
DE
UK
DE
ES
ES
UK
IE
LV
Method to induce resistance against
Cucurbit yellow stunting disorder Virus
(CYSDV)
Method for detection of b-D-Glucan-
producer bacteria useful for food
industries
Generation of Stable Cell Lines with
Enhanced Recombinant Protein
Production
Genes related to type 2 diabetes and
obesity
RNA (ribonucleic acid) silencing for use
in development of therapeutic products
for treatment of various diseases
including cancer
NF-Kappa B Nuclear Transcription Factor
Inhibitor
Mouse model system for foot-and-mouth
disease (FMDV) infection
Tumour marker: p53 Autoantibodies
Bespoke health data analysis
New kit for safe puncture, withdrawal
and disposal of blood and other body
fluids
Conidiogenone, a natural product
sporulation inducer for Penicillium spp
for food and agrochemical industries
Information system for smart cards
without contacts
Dynamic Sports Alert Application for
Java Enabled 2.5G and 3G Handsets
Mobile Content Distribution Solution
Asynchronous motor with frontal part
winding
A Spanish research institute has developed a method to induce genetic resistance against Cucurbit yellow stunting
disorder virus (CYSDV). This virus causes important economic losses in cucurbits crops and there was no method available
to generate resistance against it. The use of the plants obtained by this technology with improved CYSDV genetic
resistance would increase the crops yield and reduce the economic losses caused by CYSDV. License agreements with seeds
producing companies are sought.
Two Spanish universities and a research centre have developed a new and fast method to detect bacteria producing an
exopolysaccharide of b-D-Glucan type. The utilisation of this method could allow prevention of ropiness in alcoholic
beverages as well as isolation of new food-fermenting bacterial strains. They are looking for a laboratory involved in
microbiological analysis or a company producing molecular systems for microbiological analysis interested in a license
agreement.
A German SME is offering a technology for the development of stable transfected cell lines. The technology is used for
development of cell-based assays and the generation of production cell lines. The system makes use of chromatin
modifying sequences resulting in more stable and enhanced protein production. The company is interested in license
agreements, co-developing as well as providing this technology for customers on a service basis.
A research group of a Catalan university (Spain) has identified genes implied in the alterations present in type 2 diabetes
and obesity. Polymorphisms on these genes are associated with these diseases, so the group proposes methods and kits
for their early diagnosis and treatment. The group is looking for joint venture agreements, but other collaborations may
be considered.
Israeli researchers found that small nucleolar RNA in three trypanosome species can be silenced by a novel mechanism
related to RNA interference (RNAi) that was termed snoRNAi. Silencing was achieved either by expressing anti-sense RNA
or by production of double-stranded RNA (dsRNA) specific to the gene using two opposing T7 promoters. This is the first
report to suggest the RNAi can be used to silence small stable RNAs. Strategic partners for further development of the
research are sought.
The invention consists of a kinase shown to act as an NF-Kappa B inhibitor by leading scientists at a German university.
Its main advantage consists of inhibiting NF-Kappa B activity very specifically and thereby influencing basic cellular
processes. This makes it a powerful tool for basic scientific research and a promising candidate in cancer therapy. The
university is looking for licensees involved in development of novel reagents for the scientific study of human biology and
diseases.
A research institute belonging to the Spanish Council for Scientific Research has developed a murine model in which adult
mice are infected by FMDV (Foot-and-mouth disease virus), causing a systemic infection. This mouse model may facilitate
the development of new effective vaccines and antiviral products for FMDV. They are looking for a company involved in
veterinary area and interested in developing new FMDV vaccines.
A German SME is offering a tumour-marker test kit. This test enables the determination of p53 auto-antibodies in the
sera of tumour patients. p53 autoantibodies have a potential to monitor early diagnosis of tumour relapse after surgery
of colon cancer patients. The product is CE certified by the German Competent Authority. The company offer an ELISA test
kit containing all reagents in a "ready to use" format.
A Welsh company has developed a database "The Health Outcomes Data Repository" for evaluation of medical provision.
It has been designed for pharmaceutical companies and healthcare providers, producing unique and valuable data for
quantification of medical treatment. The company seeks partners that require assistance in understanding the field of
healthcare and the benefits of their products to support product development, positioning and marketing.
A German inventor developed a new kit for safe puncture, withdrawal and disposal of blood and other body fluids.
Partnership with a producer for the kit already exists. Now they are looking for partners to commercialise the invention
abroad.
The School of Chemistry of the University of Basque Country in Spain has developed a technology to produce and use
natural compounds that induce the sporulation of Penicillium spp. fungus. This technology allows producing spores in
liquid cultures used in food industry or bio control process. Partners from agrochemical and pharmaceutical industry are
being sought for the development a commercial product by themselves or through cooperation agreements with the
institution.
A Spanish public university has developed a system of reception-emission of information for smart cards without contacts
that allows the use of very low frequency fields (below 100 kHz). Thus, the screening problems of present techniques are
avoided. The research team looks for collaboration with public or private companies for patent license.
A Scottish SME has developed and patented (pending) dynamic 3D goal flashes for mobile infotainment applications
across a wide range of sports. The low-cost application provides 3D goals direct to a Java enabled handset within seconds
of their being scored. The client-side scaleable technology provides a service at a significantly lower cost than 3G video
clips. The company seeks sports clubs, sports media or mobile handset or service operators to enter into license
agreements.
An Irish company has a generic hosted platform that can be integrated into any organisation’s operation to enable the
management, distribution and "Over The Air" (OTA) delivery of mobile content. Their offering is suitable for large on-line
retailers (such as Amazon) to small online retailers that wish to enable their offering to include mobile content (graphics,
games, music, applications, etc.). Partnerships sought may include license or commercial agreements with technical
assistance.
A Latvian research group from technical university has developed a new, simple and cheap solution for control of starting
and transition processes of asynchronous motors. The research group is looking for companies that want to complete
technical design and to start manufacturing the modified asynchronous motors.
A G R I C U L T U R E A N D M A R I N E R E S O U R C E S
A G R O F O O D I N D U S T R Y
B I O L O G I C A L S C I E N C E S
E L E C T R O N I C S , I T A N D T E L E C O M M S
∫ø¢π∫√™
ƹƤê
¶ ∂ ƒ π § ∏ æ ∏
̿İ